NHC CFO gifts 500 shares of common stock

National Healthcare Corp’s SVP and CFO, Brian F. Kidd, reported a Form 4 showing a bona fide gift of 500 shares of common stock at $0.00 per share, leaving him with 29,996 common shares held directly.

Accepted by SEC EDGAR 06/18/2026 - 04:04 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

National Healthcare Corp’s SVP and CFO, Brian F. Kidd, reported a Form 4 showing a bona fide gift of 500 shares of common stock at $0.00 per share, leaving him with 29,996 common shares held directly.

The filing also details his outstanding stock options on common stock, including 14,000 underlying shares at $157.13 expiring on February 23, 2031, 9,000 shares at $90.62 expiring on February 24, 2030, 4,000 shares at $94.10 expiring on March 5, 2029, and 4,147 shares at $53.94 expiring on March 8, 2028.

Insider Trade Summary

500 shares gifted

Gift 1 txn

Insider KIDD BRIAN F

Role SVP, CFO

Type	Security	Shares	Price	Value
Gift	Common Stock	500	$0.00	$0.00
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Common Stock — 29,996 shares (Direct); Option to Purchase Common Stock — 31,147 contracts (Direct)

Key Figures

Gifted shares: 500 shares Shares held after gift: 29,996 shares Option grant 1: 14,000 shares at $157.13 +3 more

6 metrics

Gifted shares 500 shares Bona fide gift of common stock at $0.00 per share

Shares held after gift 29,996 shares Direct common stock holdings following transaction

Option grant 1 14,000 shares at $157.13 Option to purchase common; expires February 23, 2031

Option grant 2 9,000 shares at $90.62 Option to purchase common; expires February 24, 2030

Option grant 3 4,000 shares at $94.10 Option to purchase common; expires March 5, 2029

Option grant 4 4,147 shares at $53.94 Option to purchase common; expires March 8, 2028

Key Terms

Option to Purchase Common Stock, Bona fide gift, non-derivative, underlying security shares

4 terms

Option to Purchase Common Stock financial

"security_title: Option to Purchase Common Stock; underlying security is Common Stock"

Bona fide gift financial

"transaction_code_description: Bona fide gift for 500 shares of Common Stock"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

non-derivative financial

"transaction_type: non-derivative for the 500-share common stock gift"

underlying security shares financial

"underlying_security_shares: 14,000.0000, 9,000.0000, 4,000.0000, 4,147.0000"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHC CFO Brian F. Kidd report on this Form 4?

Brian F. Kidd reported a bona fide gift of 500 shares of National Healthcare Corp common stock. The gift was recorded at $0.00 per share, meaning there was no sale and no cash proceeds associated with this disposition.

How many National Healthcare Corp shares does the NHC CFO hold after the gift?

Following the 500-share gift, Brian F. Kidd directly holds 29,996 shares of NHC common stock. This figure reflects his remaining non-derivative ownership after the reported transaction on the Form 4 filing date.

What stock option positions for NHC does the Form 4 show for the CFO?

The Form 4 lists several options to purchase NHC common stock, including 14,000 underlying shares at $157.13 and 9,000 at $90.62, plus smaller grants, each with specific future expiration dates extending through 2031.

Did the NHC CFO buy or sell shares on the open market in this filing?

No open-market purchases or sales are reported. The only non-derivative transaction is a bona fide gift of 500 shares, which is a non-cash transfer and not a market trade in National Healthcare Corp stock.

What are the key exercise prices and expirations of the NHC CFO’s options?

Reported options include grants with exercise prices of $157.13, $90.62, $94.10, and $53.94 per share. Their expiration dates range from March 8, 2028, up to February 23, 2031, covering multiple future years.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIDD BRIAN F

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		G		500	D	$0	29,996	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	4,147		4,147	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	4,000		4,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	9,000		9,000	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

	/s/ Brian Kidd	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)